OTC · Drug Manufacturers - Specialty & Generic

BioHarvest Sciences Inc. (CNVCF) Stock

$6.30 OTC: CNVCF Healthcare

BioHarvest Sciences Inc., along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant.

Valuation

MetricValue
Price$6.30
Market Cap$109.16M
P/E Ratio-7.06
P/B Ratio68.81
P/S Ratio3.89
EPS (TTM)$-0.93
52-Week High$6.30
52-Week Low$6.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE190.98%
ROA-51.65%
ROCE-65.06%
Gross Margin55.35%
Operating Margin-27.75%
Net Margin-51.27%
Debt/Equity10.39
Current Ratio0.55

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$2.0M$5.0M$13.0M
Operating Profit$-2.0M$-6.0M$-8.0M$-11.0M$-10.0M
Net Profit$-5.0M$-7.0M$-10.0M$-11.0M$-13.0M
EPS$-1.80$-0.68$-0.79$-0.86$-0.93
Op Margin-1059.6%-1557.1%-403.9%-193.0%-78.7%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$2.0M$5.0M$10.0M$9.0M$15.0M
Total Liabilities$29.0M$8.0M$7.0M$15.0M$30.0M
Cash$1.0M$2.0M$4.0M$2.0M$5.0M
Borrowings$24.0M$3.0M$2.0M$11.0M$22.0M

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-2.0M$-4.0M$-7.0M$-9.0M$-9.0M
Investing Cash Flow$0$0$-3.0M$-3.0M$-3.0M
Financing Cash Flow$2.0M$0$4.0M$1.0M$0
Net Cash Flow$0$1.0M$2.0M$-2.0M$4.0M
Free Cash Flow$-2.0M$-4.0M$-8.0M$-10.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.36
EV / EBITDA-15.81
FCF Yield-9.72%
Quick Ratio0.29
Interest Coverage-1.48
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADOIFAdocia S.A. $8.87 +0.00% -4.21 $103.66M 0.00%
AMEUFAnteris Technologies Ltd $5.70 -35.81% -3.37 $120.50M 0.00%
COPHFCreso Pharma Limited $0.12 +0.00% -0.40 $131.72M 0.00%
CSAMFCSAM Health Group AS $4.82 +0.00% -21.09 $98.80M 1.27%
EOFBYEcofibre Limited $0.84 +0.00% -0.17 $73.67M 0.00%

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc., along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant. BioHarvest is responsible for the entire process, from designing and developing to manufacturing and marketing its offerings. These include Vinia, a nutraceutical powder derived from red grapes, as well as its medical cannabis line. The firm's main operational base is located in Vancouver, Canada.

BioHarvest Sciences Inc. is headquartered in CA.

BioHarvest Sciences Inc. (CNVCF) stock trades at $6.30 with a market capitalization of $109.16M. The stock is valued at a price-to-earnings (P/E) ratio of -7.06, price-to-book of 68.81, price-to-sales of 3.89. Over the past 52 weeks the stock has ranged between $6.30 and $6.30, and currently trades at its 52-week high.

On profitability, BioHarvest Sciences Inc. generates a return on equity (ROE) of 190.98% — well above the market average, a sign of a high-quality business, return on capital employed of -65.06%, an operating margin of -27.75%, a net profit margin of -51.27%.

Official website: www.bioharvest.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides